Literature DB >> 8177381

Expression of fibroblast growth factor receptor-1 in human glioma and meningioma tissues.

T Ueba1, J A Takahashi, M Fukumoto, M Ohta, N Ito, Y Oda, H Kikuchi, M Hatanaka.   

Abstract

We examined the expression of fibroblast growth factor receptor-1 (FGFR-1), namely FLG, in tissues of 18 human gliomas, 10 human meningiomas, 3 human metastatic brain tumors, and 2 normal human brains by means of immunohistochemistry. All tissues were positively stained for FGFR-1. Primary brain tumors were more abundantly immunoreactive than normal brain tissues (Mann-Whitney U test, P < 0.05). There was significant correlation between the expression level of basic fibroblast growth factor (basic FGF) and that of FGFR-1 in tissues of human glioma (Spearman's test, P < 0.05). The expression level of FGFR-1 of tumor cells increased in correlation with that of endothelial cells in glioma tissues (Spearman's test, P < 0.001). We previously reported that basic FGF is produced in more than 90% of human glioma and meningioma tissues. Together with these data, it is suggested that basic FGF is involved in autonomous cell growth and tumorigenesis of gliomas and meningiomas as an autocrine growth factor in vivo.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8177381     DOI: 10.1227/00006123-199402000-00003

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  17 in total

1.  Heterogeneity of chemosensitivity in six clonal cell lines derived from a spontaneous murine astrocytoma and its relationship to genotypic and phenotypic characteristics.

Authors:  R Bradford; H Koppel; G J Pilkington; D G Thomas; J L Darling
Journal:  J Neurooncol       Date:  1997-09       Impact factor: 4.130

Review 2.  Biology of angiogenesis and invasion in glioma.

Authors:  Matthew C Tate; Manish K Aghi
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

Review 3.  Angiogenic growth factors in neural embryogenesis and neoplasia.

Authors:  D Zagzag
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

Review 4.  Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs.

Authors:  I F Dunn; O Heese; P M Black
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

5.  A phase II trial of PTK787/ZK 222584 in recurrent or progressive radiation and surgery refractory meningiomas.

Authors:  Jeffrey J Raizer; Sean A Grimm; Alfred Rademaker; James P Chandler; Kenji Muro; Irene Helenowski; Laurie Rice; Katie McCarthy; Sandra K Johnston; Maciej M Mrugala; Marc Chamberlain
Journal:  J Neurooncol       Date:  2014-01-22       Impact factor: 4.130

Review 6.  Mitogenic signaling and the relationship to cell cycle regulation in astrocytomas.

Authors:  A Besson; V W Yong
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

7.  Antiangiogenic therapy and mechanisms of tumor resistance in malignant glioma.

Authors:  Ruman Rahman; Stuart Smith; Cheryl Rahman; Richard Grundy
Journal:  J Oncol       Date:  2010-04-11       Impact factor: 4.375

8.  Progress on antiangiogenic therapy for patients with malignant glioma.

Authors:  Manmeet S Ahluwalia; Candece L Gladson
Journal:  J Oncol       Date:  2010-04-06       Impact factor: 4.375

9.  Transcriptional regulation of basic fibroblast growth factor gene by p53 in human glioblastoma and hepatocellular carcinoma cells.

Authors:  T Ueba; T Nosaka; J A Takahashi; F Shibata; R Z Florkiewicz; B Vogelstein; Y Oda; H Kikuchi; M Hatanaka
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

Review 10.  New molecular targets in angiogenic vessels of glioblastoma tumours.

Authors:  Joshua C Anderson; Braden C McFarland; Candece L Gladson
Journal:  Expert Rev Mol Med       Date:  2008-08-07       Impact factor: 5.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.